Abstract: G-protein-coupled receptors (GPCRs) are the largest family of membrane-bound receptors and constitute about 50 %ofall knowndrug targets.They offer great potential for membrane protein nanotechnologies.W er eport here ac harge-interaction-directed reconstitution mechanism that induces spontaneous insertion of bovine rhodopsin, the eukaryotic GPCR, into both lipid-and polymer-based artificial membranes.W er eveal an ew allosteric mode of rhodopsin activation incurred by the non-biological membranes:t he cationic membrane drives atransition from the inactive MI to the activated MII state in the absence of high [H + ]ornegative spontaneous curvature.W ea ttribute this activation to the attractive charge interaction between the membrane surface and the deprotonated Glu134 residue of the rhodopsinconserved ERYs equence motif that helps break the cytoplasmic "ionic lock". This study unveils anovel design concept of non-biological membranes to reconstitute and harness GPCR functions in synthetic systems.
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Membrane proteins are biologically derived high-performance materials that mediate matter transport, information processing, and energy conversion across nanoscale cellular boundaries,a nd pose great potential for bio-nanoengineering.
[1] Bovine rhodopsin is acanonical prototype of G-proteincoupled receptors (GPCRs), the largest family of membrane proteins (MPs) in the human genome,and the most frequent drug targets.
[2] Understanding GPCR activation mechanisms is far reaching in terms of GPCR-based biological signaling, as well as pharmaceutical development. [3] Here,w ei llustrate how GPCR activation is affected by specific allosteric interactions in the case of visual rhodopsin. Forb io-nanotechnologies,t he broad utility of GPCRs is limited by the fluidic and labile nature of biomembranes.Putting GPCRs to work faces two upmost unanswered challenges:1 )how to reconstitute GPCRs in robust and scalable synthetic membranes,a nd 2) how does the non-biological membrane affect the activities of GPCRs?
Conventional methods of reconstituting MPs rely critically on detergent solubilization or sonication forces to destabilize membranes,f ollowed by external removal of detergent;t his eventually drives at ransition from MPdetergent-membrane micelles to proteomembranes.
[4] The utility of this approach for robust, non-fluidic membranes resisting such destabilization is unclear. An ew,c hargeinteraction-directed reconstitution (CIDR) paradigm [5] was proposed to induce preferential contact between aM P hydrophilic domain and the membrane by charge attraction, which triggers MP insertion and decortication of detergent micelles associated with the MP hydrophobic domain. Formation of proteomembranes occurs spontaneously without needing external means for detergent removal. [5] CIDR of functional proteorhodopsin [5, 6] and bacterial reaction center, [7] the two prokaryotic MPs differing greatly in structural complexity,h as been reported in both lipid-and polymer-based membranes,even when the membranes are in an entangled or "frozen" state with greatly enhanced stability. While proton pumping kinetics mediated by proteorhodopsin are allosterically slowed down as the polymer membrane block size increases and flexibility decreases, [6] reaction center-mediated electron-transport kinetics appear insensitive. [7] These studies suggest the broad utility of CIDR for developing robust and scalable MP-based bio-nanotechnologies,potentially including eukaryotic GPCRs.
We show that CIDR indeed induces spontaneous and functional reconstitution of bovine rhodopsin into both lipidand polymer-based artificial membranes that differ greatly from retinal disk membranes (RDM) in terms of lipid composition and charge state,b oth of which are regarded to play crucial roles in rhodopsin activation. [8] Native RDM contain primarily lipids with phosphocholine (PC), phosphoethanolamine (PE), and phosphoserine (PS) headgroups with 47 %d ocosahexaenoic acid (22:6w3) acyl chains.T he mechanistic roles of these lipids are explained by 1) the flexible surface model (FSM), [8d,e] which proposes that the negative spontaneous curvature of PE lipids helps offset the solvation energy cost at the protein-lipid-water interface of activated MII;
[8a-g] 2) high [H + ]c ondensed on the membrane surface because of negatively charged PS lipids,w hich shifts the MI-MII equilibrium toward MII;
[8i-l] and 3) specific lipidrhodopsin interactions, [8g,h] such as Hbonding between PE headgroups and newly exposed protein residues upon MII formation.
[8g] We reveal here ac ompletely new mode of rhodopsin activation in non-biological membranes that does not fit into any of these mechanisms (Figure 1 ).
We first examined CIDR of bovine rhodopsin in lipidbased artificial membranes with negative spontaneous curvature.S ince rhodopsin has an isoelectric point of 6.2 [9] and is overall anionically charged at physiological pH, we chose 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), a non-biological cationic lipid, and mixed it with zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Unlike DOPE, the DOTAP has zero spontaneous curvature. [10] We prepared three model membranes,80/20, 50/ 50, and 20/80 DOTAP/DOPE, respectively,w ith increasing negative membrane curvature.T he CIDR of bovine rhodopsin solubilized by n-dodecyl-b-d-maltoside (DDM) into all model DOTAP/DOPE membranes triggers as pontaneous transition from free-suspending spherical liposomes to acondensed phase of proteoliposome complexes (see the Supporting Information). Synchrotron small-angle X-ray scattering (SAXS) of all complexes revealed equally spaced harmonics characteristic of am ultilamellar structure.A sa ne xample shown in Figure 2a ,the first scattering peak (q 001 )iscentered at 0.113 and 0.114 À1 ,r espectively,f or 80/20 and 20/80 DOTAP/DOPE, indicating ap roteomembrane lamellar periodicity of 55-56 s imilar to the transmembrane dimension of reconstituted proteorhodopsin as previously reported.
[5a,b] This lamellar periodicity does not support the presence of DDM micelles either with the membrane or bovine rhodopsin. Them aximum possible residual DDM after re-dispersing the condensed proteomembrane complexes in ad etergent-free buffer for functional characterization is negligible (see the Supporting Information).
Photoactivation of rhodopsin involves breaking two "ionic locks" accompanied by as eries of spectroscopically distinct photointermediates: [11] starting from the dark state (A max = 500 nm), retinal isomerization leads to MI formation (A max = 480 nm). Subsequent disruption of the first interhelical "ionic lock" by internal proton transfer from the retinal protonated Schiff base (PSB) to its counterion, Glu113, on the extracellular side of rhodopsin leads to MII a formation (A max = 380 nm). Although ab lue shift of the UV/Vis absorption maximum (500!380 nm) is as trong indication of rhodopsin activation, only disruption of the second "ionic lock" between Glu134 and Arg135 of the rhodopsin-conserved ERYsequence motif puts the protein in the activated MII b state (A max = 380 nm), as it is associated with the motion of transmembrane helix 6( TM6) that sets the helix-loop conformation for transducin interaction. This second unlocking event, as assessed by FTIR and EPR spectroscopy, [11d,e] gives rise to the pH dependence of the MI-MII equilibrium favoring fully active MII b H + at acidic pH, because protonation of Glu134 is enthalpically downhill.
Given the favorable role of negative membrane spontaneous curvature on rhodopsin activation, [8a-g] we expect to observe as hift of the MI-MII equilibrium toward MII at increasing DOPE concentration. What we actually observed is completely on the contrary.T he UV/Vis spectra of rhodopsin in all DOTAP/DOPE membranes upon photoactivation (measured at pH 6.9 and room temperature) revealed as imilar blue shift of the absorption maximum (Figure 2b) , indicative of MII formation that is independent of membrane curvature.T od etermine the pH-dependent equilibrium between inactive MI and activated MII, we performed pH titration studies of all proteoliposome complexes at 10 8 8C. It has been shown [11e,i] that at 10 8 8Ca ll MII observed by UV/Vis spectra is the active MII observed by FTIR spectroscopy.T he contribution of the activated MII state to the photoproduct equilibrium (q)w as determined from the photoproduct minus dark state UV/Vis difference spectra, fit with the Henderson-Hasselbalch function when possible (Supporting Information), and plotted as af unction of pH (Figure 2c ). ThepHtitration curve of native rhodopsin in RDM at 10 8 8Cisalso plotted as acomparison. Surprisingly, for proteoliposome membranes with low negative spontaneous curvature,that is,80/20 DOTAP/DOPE, which should deter MII formation and shift the transition to more acidic pH as compared to RDM, we observed no transition at all. Instead, 100 %a ctivated MII was observed in the entire pH range (5-10) that we tested. Thes ame behavior was true for 50/50 DOTAP/DOPE. When the negative membrane curvature is further increased (i.e.20/80 DOTAP/DOPE), however, we observed atransition at alkaline pH, albeit with anon-zero end-point value indicating 80 %photoproduct was still in the activated MII state.T his observation is not consistent with previous explanations for rhodopsin activation involving negative membrane curvature, [8a-g] and suggests an additional activation mechanism despite the unfavorable solvation energy costs at the protein-lipid-water interface.
One possible player is the cationic lipid DOTAPshown in Figure 2 (inset). To reduce or eliminate the contribution from negative spontaneous curvature and specific DOPE-rhodopsin interactions [8g] to rhodopsin activation, we replaced DOPE with zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and prepared as eries of DOTAP/DOPC membranes with increasing membrane charge density,t hat is,2 0/ 80, 50/50, 80/20, and 100/0 DOTAP/DOPC,respectively.Like DOTAP,the DOPC also has zero spontaneous curvature.
[10b]
We observed spontaneous CIDR of DDM-solubilized bovine rhodopsin into all DOTAP/DOPC membranes to form condensed proteoliposome complexes,a nd synchrotron SAXS studies of these complexes revealed am ultilamellar structure.A sa ne xample shown in Figure 3a [8i-l] Taken together,c ationic and planar DOTAP/DOPC membranes should strongly favor the MI state,b ecause the cationic membrane surface potential would have an opposite effect. What we observed is,again, completely on the contrary.T he UV/Vis spectra of rhodopsin in all DOTAP/DOPC membranes upon photoactivation showed similar MII formation (Figure 3b ). In addition pH titration studies of proteoliposome complexes at 10 8 8C ( Figure 3c )c learly show that all DOTAP/DOPC membranes favor the rhodopsin MII state even at alkaline pH, and acid denaturation controls (A max = 440 nm) indicate aP SB rather than free retinal (A max = 383 nm;S upporting Information). Consistent with what is observed in the DOTAP/DOPE system, the higher the percentage of DOTAPi nt he membranes,t he higher the fraction of activated MII state.W hen DOTAP reaches 80 % or more,t he alkaline end point is unity,t hus revealing fully active MII in the entire pH range (5-10).
[11e]
Ther ole of DOTAP on activating rhodopsin could be attributed to specific DOTAP-rhodopsin interactions yet to be identified, or to its cationic membrane surface.T orule out the contribution from specific DOTAP-rhodopsin interactions,and to test the broad utility of CIDR on reconstituting the eukaryotic GPCR in robust and scalable synthetic membranes,w es ynthesized aw ell-defined amphiphillic triblock copolymer by atom-transfer radical polymerization, polybutadiene 35 -b-(poly(4-vinyl-N-methylpyridine iodide) 30 ) 2 , that is,P BD 35 -b-(P4MVP 30 ) 2 (Supporting Information, also see the inset of Figure 4b for its structure). Unlike polymeric surfactants such as NVoy,SMAs,and Amphipols that are used to solubilize MPs, [12] the amphiphilic triblock copolymer selfassembles in water into liposome-like polymersomes (Supporting Information, also see the inset of Figure 4a )w ith ac ationic membrane charge density that is an order of magnitude higher than DOTAP membranes.
[5c] Due to the symmetric structure of the triblock copolymer, the polymersome membrane has zero spontaneous curvature.
We observed, for the first time,spontaneous CIDR of the eukaryotic GPCR in the robust synthetic block copolymer membranes.S ynchrotron SAXS of the proteopolymersomes revealed three equally spaced harmonics characteristic of amultilamellar structure (marked by arrows, Figure 4a ). The scattering is not as sharp as that of proteoliposomes,m ost likely due to amore diffusive hydrophilic-hydrophobic interface.T he first scattering peak (q 001 )i sc entered at 0.107 À1 , indicating ap roteomembrane lamellar periodicity of 59 . Despite that rhodopsin is reconstituted in an entirely synthetic polymer membrane without any lipid component, UV/Vis spectra of the proteopolymer membranes upon photoactivation still revealed MII formation (Figure 4b ), and pH titration at 10 8 8C ( Figure 4c )c onfirmed fully active MII with an alkaline end point unity in the entire pH range (5-10). It becomes clear that the cationic membrane surface charge is associated with anew mode of rhodopsin activation: the higher the cationic membrane surface charge density,the higher the fraction of activated MII state in the photoproduct equilibrium.
We attribute this new mode of activation to the attractive charge interaction between the membrane and the deprotonated Glu134 residue of the rhodopsin-conserved ERY sequence motif that helps break the cytoplasmic "ionic lock" (Figure 1 ). To further investigate cationic stabilization of Glu134, we also conducted anew analysis of microsecondscale molecular dynamics (MD) simulations of bovine rhodopsin in ar ealistic biomembrane model (Supporting Information). Themajor new finding shows that Glu134 may form direct salt bridges with membrane-supported cationic moieties through achannel opening between TM4 and TM5. Because Glu134 is situated at the interface between the lipid bilayer and the aqueous phase, [11c] the ERYionic lock can be affected by charge neutralization involving cationic lipids or polymersomes.O ur MD simulations are consistent with previous FTIR studies [11g] and X-ray structural data for active rhodopsin [13] (Supporting Information). Photoactivation of rhodopsin involves breaking two "ionic locks" accompanied by ac onformational change to dock transducin. [11] At low temperature ( 10 8 8C), release of both "ionic locks" are coupled, in that protonation of Glu134 helps offset the free-energy costs associated with breaking the first "ionic lock", whereas at higher temperature release of both "ionic locks" becomes partially uncoupled.
[11e] Ar elease of both "ionic locks" is required for full receptor activation, but the activating movement of TM6 is independent of H + uptake by Glu134. Our data suggest that in synthetic systems,the role of H + can be replaced with cationic membrane surface moieties positioned in close proximity to Glu134 on the rhodopsinconserved ERYs equence motif. [14] In support of this interpretation, we have also carried out ATR-FTIR measurements of the light-induced binding of ah igh-affinity transducin peptide to rhodopsin in DOTAPv ersus the RDM control (Supporting Information). Forthe ATR-FTIR measurements, alight-induced difference signal is obtained due to structural changes of the MII/peptide complex, including protonation of Glu134 in the transducin-bound state.
[11g] Thed ifference signal is attributed to the "extra MII" [15] because of the active MII b H + state.A ctive MII is produced and in each case the spectral difference entails destabilization of the ionic lock because of Glu134 of the E(D)RYsequence motif.
[11e] Hence we conclude that DOTAP,p olymerosomes,a nd the highaffinity transducin peptide all exert their actions by stabilizing the active MIIH + state,i nw hich the ionic lock involving Glu134 of the E(D)RYsequence motif is broken giving "extra MII".
In summary,w ereport here for the first time the broad utility of CIDR for inducing spontaneous and functional reconstitution of bovine rhodopsin, ac anonical prototype of eukaryotic GPCRs.T he CIDR makes it possible to prepare robust and scalable proteomembrane arrays in both 3D and 2D [16] by spontaneous self-and directed-assembly processes amenable to many engineering systems.W efurther show that photoactivation of rhodopsin proceeds in robust synthetic polymer membranes without any biological lipid component. Finally,w ed iscovered an ew mode of rhodopsin activation triggered by the attractive charge interaction between the membrane and the deprotonated Glu134 residue of the rhodopsin-conserved ERYs equence motif.W ee xpect that the role of H + at the membrane interface under physiological conditions is replaceable by aw ide range of cationic membrane surface moieties in synthetic systems,w hich form ionic bonds with Glu134 and provide as imilarly favorable thermodynamic driving force to shift the MI-MII equilibrium toward activated MII. Given that Glu134 in rhodopsin is part of ah ighly conserved triad, D(E)RY, our study implies that the observed effect will be transferrable to other rhodopsinlike GPCRs in synthetic systems. 
